Cargando…

Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma

Background: Therapeutic options for treating advanced or metastatic medullary thyroid carcinoma (MTC) and anaplastic thyroid carcinoma (ATC) are still limited in Japan, even though vandetanib for MTC and lenvatinib for MTC and ATC have been approved. Sorafenib is an oral multikinase inhibitor approv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Yasuhiro, Onoda, Naoyoshi, Ito, Ken-ichi, Sugitani, Iwao, Takahashi, Shunji, Yamaguchi, Iku, Kabu, Koki, Tsukada, Katsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Thyroid Cancer and Nodules
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646744/ https://www.ncbi.nlm.nih.gov/pubmed/28635560 http://dx.doi.org/10.1089/thy.2016.0621

Ejemplares similares

Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan
por: Sugitani, Iwao, et al.
Publicado: (2019)

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
por: Dierks, Christine, et al.
Publicado: (2021)

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier
por: Randolph, Gregory W., et al.
Publicado: (2022)

Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997–2014: A Nationwide Study
por: Mathiesen, Jes Sloth, et al.
Publicado: (2019)

Routine Chest Computed Tomography at Presentation Does Not Identify Distant Metastasis in cT1aN0 Papillary Thyroid Carcinoma
por: Kawano, Shiori, et al.
Publicado: (2020)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience
por: Miyauchi, Akira, et al.
Publicado: (2023)

Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
por: Schürch, Christian M., et al.
Publicado: (2019)

Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance
por: Sasaki, Takahiro, et al.
Publicado: (2023)

Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas
por: Ito, Yasuhiro, et al.
Publicado: (2019)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital
por: Ito, Yasuhiro, et al.
Publicado: (2016)

Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery
por: Oda, Hitomi, et al.
Publicado: (2016)

Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma
por: Sasaki, Takahiro, et al.
Publicado: (2021)

Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial
por: Huillard, Olivier, et al.
Publicado: (2019)

Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option
por: Ito, Yasuhiro, et al.
Publicado: (2018)

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
por: Capdevila, Jaume, et al.
Publicado: (2022)

Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib
por: Taylor, Matthew H., et al.
Publicado: (2021)

Cardiac Metastasis From Anaplastic Thyroid Carcinoma
por: Gonzalez, Michelle N Garcia, et al.
Publicado: (2021)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

SUN-610 Thyroid Storm and Hypoparathyroidism Caused by Anaplastic Thyroid Carcinoma
por: Oben Perez, Laura, et al.
Publicado: (2019)

Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
por: Yoshida, Yusaku, et al.
Publicado: (2020)

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
por: Lee, Eun Kyung, et al.
Publicado: (2022)

Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation
por: Nikita, Maria Eleni, et al.
Publicado: (2016)

Cortisol Deficiency in Lenvatinib Treatment of Thyroid Cancer: An Underestimated Common Adverse Event
por: Monti, Salvatore, et al.
Publicado: (2022)

Performance of a Multigene Genomic Classifier in Thyroid Nodules with Suspicious for Malignancy Cytology
por: Skaugen, John M., et al.
Publicado: (2022)

Monopolar Radiofrequency Ablation of Thyroid Nodules: A Prospective Austrian Single-Center Study
por: Dobnig, Harald, et al.
Publicado: (2018)

A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study
por: González, Hernán E., et al.
Publicado: (2017)

A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis
por: Ramírez-Moya, Julia, et al.
Publicado: (2021)

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
por: Onoda, Naoyoshi, et al.
Publicado: (2020)

Medullary Carcinoma of Thyroid Due to GLP-1 Receptor Agonist
por: Vemula, Hasitha, et al.
Publicado: (2021)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017)

A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer
por: Sawka, Anna M., et al.
Publicado: (2020)

ODP497 Multifocal Papillary Thyroid Carcinoma with Anaplastic Dedifferentiation
por: Jacinto, Jorg Jurgen N, et al.
Publicado: (2022)

A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials
por: Zafereo, Mark, et al.
Publicado: (2020)

The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients
por: Craig, Steven J., et al.
Publicado: (2020)

A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules
por: Finkelstein, Sydney D., et al.
Publicado: (2022)

SUN-LB77 Incidental Anaplastic Thyroid Carcinoma: An Uncommon Entity
por: Padmanaban, Preethi, et al.
Publicado: (2020)

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
por: Nikiforov, Yuri E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n0vhos1bk4b6fcim2p2tihmevd